This site is intended for Healthcare Professionals only.

Denmark study finds how a drop of blood can detect HIV, hepatitis B, hepatitis C

Date:

Share post:

At the European Conference of Clinical Microbiology & Infectious Diseases (ECCMID) this year in Copenhagen, Denmark, data on a test that may detect HIV, hepatitis B, and hepatitis C from a single drop of blood are being presented.

Hepatitis B or C claim the lives of over a million people each year. Every year, 1.5 million individuals contract HIV, and 650,000 people pass away from HIV-related causes.

The World Health Organisation has made the elimination of all three viruses by 2030 one of its global health strategies but new tests are necessary if case numbers are to be reduced.

The most common test for hepatitis B, hepatitis C and HIV involves taking a blood sample from a vein using a needle. While this method works extremely well, there is a potentially large reservoir of the three conditions in places where this method is not suitable.

This could be prisons, drug rehabilitation centres and homeless shelters, where the taking of venous blood samples isn’t always suitable or countries in which the shipping and refrigerated storage of blood samples can be challenging.

Alternatives include dried blood spot tests, in which a single spot of blood is tested for nucleic acid from the three viruses.

Stephen Nilsson-Moller and colleagues at the Department of Clinical Microbiology, Copenhagen University Hospital, Denmark validated one such test.

To do the test, the individual’s finger is pricked and a few spots of blood collected on filter paper and allowed to dry.

The Hologic Panther System – testing equipment widely found in public health laboratories – then uses a technique called transcription mediated amplification to analyse one of the blood spots for genetic material from the three viruses.

The analysis is designed to be, and is normally, run on liquid samples of plasma or serum – not the dried samples used here.

Twenty samples with known amounts of HIV, hepatitis B and hepatitis C were analysed via the dried blood spot method (60 in total) and the viruses were detected in all of the samples.

The plasma was also diluted to determine the lower limit of detection. This showed that it was possible to detect the viruses at levels that are much lower than are normally found in untreated patients.

Nilsson-Moller says: “We’ve shown that using existing hospital equipment, it is possible to detect HIV, hepatitis B and hepatitis C from a single drop of blood.

“The dried blood spot test is ideal for places where you don’t want to use a needle for safety reasons or where it is less practical. This includes prisons, drug rehabilitation centres and homeless shelters.

“It is also suitable for developing countries or places where you run the risk of a blood sample being ruined before it is transferred to a laboratory that can analyse it.

“Blood samples need to be analysed within six hours when kept at room temperature, while dried blood spots can last for nine months without refrigeration.”

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Current Issue June 2024

Related articles

RPS makes Maudsley Deprescribing Guidelines available for RPS members

The Royal Pharmaceutical Society (RPS) has alerted free access to pharmacy members about a new addition to their...

Community pharmacists lead Pharmacy First digital launch

New pharmacy first platform, My Local Surgery, to connects patients with clinical services provided by community pharmacists  Community pharmacists...

CCA members celebrate hitting 200,000 Pharmacy First consultations milestone

Along with the pharmacy first celebrations, the Company Chemists Association has also highlighted the urgent need for GP...

General Election 2024: Political parties’ manifestos for community pharmacy

Political parties vow to expand the role of community pharmacy, alleviate financial strain, and establish a more sustainable...